TYK Medicines (2410.HK) Earnings Analysis
TYK Medicines (2410.HK) next reports earnings on 2026-09-02. Last quarter (2025-08-31) it beat with EPS -0.32874 HKD vs -0.32874 HKD est (0%). It has beaten estimates in 1/1 recent quarters (100%). Trailing P/E -8.28.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 2410.HK next report earnings?
| Next earnings date | 2026-09-02 |
|---|---|
| Consensus EPS estimate | n/a |
| Revenue estimate | n/a |
2410.HK earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2025-08-31 | -0.32874 HKD | -0.32874 HKD | 0% | Beat |
Beat rate: 1/1 (100%) over reported quarters with consensus data.
2410.HK valuation and analyst view
| Trailing P/E | -8.28 |
|---|---|
| Trailing EPS | -0.77965 HKD |
| Price / book | 8.43 |
| Dividend yield | 0.00% |
| Market cap | 2.95B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is TYK Medicines (2410.HK)'s next earnings date?
TYK Medicines is next scheduled to report on 2026-09-02.
Did 2410.HK beat earnings last quarter?
In its 2025-08-31 report, 2410.HK posted EPS of -0.32874 HKD versus a -0.32874 HKD estimate — a beat of 0%.
What is 2410.HK's earnings track record?
Over the last 1 reported quarters with consensus data, 2410.HK beat estimates 1 times (100%).
What is 2410.HK's current P/E ratio and EPS?
2410.HK trades at a trailing P/E of -8.28 on trailing EPS of -0.7796515646431865 HKD.
What do analysts rate 2410.HK?
2410.HK has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.